Anti-Idiotope of Anti-(NGNA-Gangliosides GM3) Mouse P3 IgM-kappa Mab

Product Information

Catalog Number	YR1143
Product Name	Anti-Idiotope of Anti-(NGNA-Gangliosides GM3) Mouse P3 IgM-kappa Mab
Molecular Name	Racotumomab
Alias	Anti-Idiotope of Anti-(NGNA-Gangliosides GM3) Mouse P3 IgM-kappa Monoclonal Antibody Recombinant Antibody, Research Grade Racotumomab
CAS Number	946832-34-4
Target	Idiotope of Anti-(NGNA-Gangliosides GM3) Mouse P3 IgM-kappa Monoclonal Antibody[Homo sapiens]
Isotype	IgG1 Kappa
Clonity	Monoclonal
Host	Mouse
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	FCM, IP, ELISA, Neut, FuncS, IF
Buffer	PBS, pH7.5
Background	Racotumomab (trade name Vaxira) is a therapeutic cancer vaccine for the treatment of solid tumors that is currently under clinical development by Recombio, an international public-private consortium with the participation of the Center of Molecular Immunology at Havana, Cuba (CIM) and researchers from Buenos Aires University and National University of Quilmes in Argentina.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price